Derbend Asset Management
- SEC CIK
- 0001874068
- Latest filing
- Apr 30, 2024
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Derbend Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q1 2024 holdings
- Shares (Q1 2024)
- 3,673
- Value
- $250.4K
- % of portfolio
- 0.1%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 3,673 | $250.4K | 0.1% | −80−2.1% | Reduced | Holders |
| Q4 2023 | 3,753 | $234.9K | 0.1% | +3,753 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −4,175−100.0% | Sold out | Holders |
| Q2 2023 | 4,175 | $234.4K | 0.2% | +4,175 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −4,585−100.0% | Sold out | Holders |
| Q3 2022 | 4,585 | $300.0K | 0.2% | −82−1.8% | Reduced | Holders |
| Q2 2022 | 4,667 | $284.0K | 0.2% | −7,047−60.2% | Reduced | Holders |
| Q1 2022 | 11,714 | $888.0K | 0.9% | 00.0% | Unchanged | Holders |
| Q4 2021 | 11,714 | $888.0K | 0.9% | −2,249−16.1% | Reduced | Holders |
| Q3 2021 | 13,963 | $1.56M | 1.5% | +1,465+11.7% | Added | Holders |
| Q2 2021 | 12,498 | $2.02M | 1.9% | – | No prior filing | Holders |